Literature DB >> 17100971

Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial.

Jörgen Wenner1, Folke Johnsson, Jan Johansson, Stefan Oberg.   

Abstract

OBJECTIVES: Esophageal pH monitoring using a wireless pH capsule has been suggested to generate less adverse symptoms resulting in improved patient acceptance compared with the catheter-based method although evidence to support this assumption is lacking. The aim of this study was to evaluate and compare the subjective experience of patients undergoing both techniques for esophageal pH monitoring.
METHODS: Using a randomized study design, patients referred for esophageal pH testing underwent both wireless and traditional catheter-based 24-h pH recording with a 7-day interval. The wireless pH capsule was placed during endoscopy and followed by 48-h pH recording. All patients answered a questionnaire, including a 10-cm visual analog scale (VAS), which described the perceived severity of symptoms and the degree of interference with normal daily activities during the pH tests.
RESULTS: Thirty-one patients, 16 women and 15 men, were included in the analysis. The severity of all adverse symptoms associated with the wireless technique was significantly lower compared with the catheter-based technique (median VAS 2.1 vs 5.1, P < 0.001). Wireless pH recording was associated with less interference with off-work activities and normal daily life, median VAS 0.6 and 0.7 compared with 5.0 and 5.7, respectively, for the catheter-based technique (P < 0.0001). Patients actively working during both tests reported less interference with normal work during the capsule-based test than during the catheter-based pH test (median VAS 0.3 vs 6.8, P= 0.005). Twenty-seven patients (87%) stated that, if they had to undergo esophageal pH monitoring again, they preferred the wireless test over the catheter-based pH test (P < 0.0001).
CONCLUSIONS: This randomized study showed that a significant majority of patients undergoing esophageal pH monitoring preferred the wireless pH capsule over the traditional catheter-based technique because of less adverse symptoms and less interference with normal daily life.

Entities:  

Mesh:

Year:  2006        PMID: 17100971     DOI: 10.1111/j.1572-0241.2006.00939.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

Review 1.  New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance.

Authors:  Jason A Wilson; Marcelo F Vela
Journal:  Curr Gastroenterol Rep       Date:  2008-06

2.  Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.

Authors:  George Triadafilopoulos; Thomas Zikos; Kirsten Regalia; Irene Sonu; Nielsen Q Fernandez-Becker; Linda Nguyen; Monica Christine R Nandwani; John O Clarke
Journal:  Dig Dis Sci       Date:  2018-06-29       Impact factor: 3.199

Review 3.  Detecting Bile Reflux-the Enigma of Bariatric Surgery.

Authors:  Thomas A Eldredge; Jennifer C Myers; George K Kiroff; Jonathan Shenfine
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

4.  Does deep sedation impact the results of 48 hours catheterless pH testing?

Authors:  Vineet Korrapati; Jay P Babich; Anil Balani; James H Grendell; Kavita R Kongara
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

5.  Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study.

Authors:  Xiao-Jun Yang; Tian Gan; Lei Wang; Zhuan Liao; Xiao-Hong Tao; Wei Shen; Xiao-Yan Zhao
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 6.  Advances in the evaluation and management of esophageal disease of systemic sclerosis.

Authors:  Dustin A Carlson; Monique Hinchcliff; John E Pandolfino
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

7.  The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.

Authors:  Eun-Young Park; Myung-Gyu Choi; Meonggi Baeg; Chul-Hyun Lim; Jinsu Kim; Yukyung Cho; Jaemyung Park; Inseok Lee; Sangwoo Kim; Kyuyong Choi
Journal:  Dig Dis Sci       Date:  2013-06-14       Impact factor: 3.199

8.  Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?

Authors:  Matthew L Bechtold; Jason-Scott L Holly; Klaus Thaler; John B Marshall
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

9.  BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.

Authors:  Cheguevara Afaneh; Veronica Zoghbi; Brendan M Finnerty; Anna Aronova; David Kleiman; Thomas Ciecierega; Carl Crawford; Thomas J Fahey; Rasa Zarnegar
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

10.  Unsedated peroral wireless pH capsule placement vs. standard pH testing: a randomized study and cost analysis.

Authors:  Christopher N Andrews; Daniel C Sadowski; Adriana Lazarescu; Chad Williams; Emil Neshev; Martin Storr; Flora Au; Steven J Heitman
Journal:  BMC Gastroenterol       Date:  2012-05-31       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.